GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015.

The result showed that revenue declined by 24.51% from N30.5 billion in Q3’2014 to N23 billion in Q3’2015.

Profit before tax also declined by 74.51% from N2.7 billion in Q3’2014 to N700 million in Q3’2015.

See Summary of result below..

GlaxoSmithkline Nigeria Plc Q3 2015 2015 2014 % Change
N’m N’m
Revenue 23,040 30,521 -24.51%
Gross Profit 7,407 10,735 -31.00%
Operating Expenses -2,511 -3,039 -17.37%
Pre-tax profits 700 2,752 -74.56%
Profit After Tax 485 1,848 -73.76%
Share Price (As at Press time)  38.20




Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.